Erratum to: the ER stress inducer DMC enhances TRAIL-induced apoptosis in glioblastoma

[This corrects the article DOI: 10.1186/2193-1801-3-495.].

[1]  D. Xie,et al.  Expression of cytoplasmic and nuclear Survivin in primary and secondary human glioblastoma , 2005, British Journal of Cancer.

[2]  D. Ashley,et al.  Analysis of FasL and TRAIL induced apoptosis pathways in glioma cells , 2001, Oncogene.

[3]  M. Siegelin.  Utilization of the cellular stress response to sensitize cancer cells to TRAIL-mediated apoptosis , 2012, Expert opinion on therapeutic targets.

[4]  J. Uddin,et al.  Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo , 2006, Molecular Cancer.

[5]  B. Pyrzyńska,et al.  TRAIL Triggers Apoptosis in Human Malignant Glioma Cells Through Extrinsic and Intrinsic Pathways , 2003, Brain pathology.

[6]  F. Stricher,et al.  Rapid and efficient cancer cell killing mediated by high-affinity death receptor homotrimerizing TRAIL variants , 2010, Cell Death and Disease.

[7]  C A Smith,et al.  Identification and characterization of a new member of the TNF family that induces apoptosis. , 1995, Immunity.

[8]  J. Olson,et al.  Heterogeneity of primary glioblastoma cells in the expression of caspase-8 and the response to TRAIL-induced apoptosis , 2011, Apoptosis.

[9]  Lei Chen,et al.  Preservation of caspase-3 subunits from degradation contributes to apoptosis evoked by lactacystin: any single lysine or lysine pair of the small subunit is sufficient for ubiquitination. , 2003, Molecular pharmacology.

[10]  A. Hsu,et al.  The cyclo-oxygenase-2 inhibitor celecoxib perturbs intracellular calcium by inhibiting endoplasmic reticulum Ca2+-ATPases: a plausible link with its anti-tumour effect and cardiovascular risks. , 2002, The Biochemical journal.

[11]  T. Aw,et al.  Gadd153 Sensitizes Cells to Endoplasmic Reticulum Stress by Down-Regulating Bcl2 and Perturbing the Cellular Redox State , 2001, Molecular and Cellular Biology.

[12]  S. Marsters,et al.  Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family* , 1996, The Journal of Biological Chemistry.

[13]  S. Fulda,et al.  Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression , 2002, Oncogene.

[14]  Hua Lu,et al.  SAG/ROC-SCF beta-TrCP E3 ubiquitin ligase promotes pro-caspase-3 degradation as a mechanism of apoptosis protection. , 2006, Neoplasia.

[15]  H. Hollema,et al.  TRAIL-receptor expression is an independent prognostic factor for survival in patients with a primary glioblastoma multiforme , 2006, Journal of Neuro-Oncology.

[16]  S. Tsutsumi,et al.  Involvement of Intracellular Ca2+ Levels in Nonsteroidal Anti-inflammatory Drug-induced Apoptosis* , 2005, Journal of Biological Chemistry.

[17]  A. López-Rivas,et al.  ER stress sensitizes cells to TRAIL through down-regulation of FLIP and Mcl-1 and PERK-dependent up-regulation of TRAIL-R2 , 2012, Apoptosis.

[18]  Sandra Healy,et al.  Stress management at the ER: regulators of ER stress-induced apoptosis. , 2012, Pharmacology & therapeutics.

[19]  J. Uddin,et al.  Aggravated endoplasmic reticulum stress as a basis for enhanced glioblastoma cell killing by bortezomib in combination with celecoxib or its non-coxib analogue, 2,5-dimethyl-celecoxib. , 2008, Cancer research.

[20]  J. Uddin,et al.  Calcium-activated endoplasmic reticulum stress as a major component of tumor cell death induced by 2,5-dimethyl-celecoxib, a non-coxib analogue of celecoxib , 2007, Molecular Cancer Therapeutics.

[21]  Fei Liu,et al.  Casticin Potentiates TRAIL-Induced Apoptosis of Gastric Cancer Cells through Endoplasmic Reticulum Stress , 2013, PloS one.

[22]  A. Stegh,et al.  The Role of Bcl-2 Family Proteins in Therapy Responses of Malignant Astrocytic Gliomas: Bcl2L12 and Beyond , 2012, TheScientificWorldJournal.

[23]  M. Keel,et al.  Endotoxin reduces CD95-induced neutrophil apoptosis by cIAP-2-mediated caspase-3 degradation. , 2004, Journal of the American College of Surgeons.

[24]  R. Kaufman,et al.  From acute ER stress to physiological roles of the Unfolded Protein Response , 2006, Cell Death and Differentiation.

[25]  T. Kwon,et al.  Monensin, a polyether ionophore antibiotic, overcomes TRAIL resistance in glioma cells via endoplasmic reticulum stress, DR5 upregulation and c-FLIP downregulation. , 2013, Carcinogenesis.

[26]  S. S. Strom,et al.  Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions , 2001, Nature Medicine.

[27]  Almer M van der Sloot,et al.  Designed tumor necrosis factor-related apoptosis-inducing ligand variants initiating apoptosis exclusively via the DR5 receptor. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[28]  J. Uddin,et al.  Dimethyl-Celecoxib (DMC), a derivative of celecoxib that lacks cyclooxygenase-2-Inhibitory function, potently mimics the anti-tumor effects of celecoxib on burkitt’s lymphoma in vitro and in vivo , 2005, Cancer biology & therapy.

[29]  A. Schönthal,et al.  COX-2 inhibition is neither necessary nor sufficient for celecoxib to suppress tumor cell proliferation and focus formation in vitro , 2008, Molecular Cancer.

[30]  K. Tanabe,et al.  Role of the unfolded protein response in cell death , 2006, Apoptosis.

[31]  P. Loehrer.  Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma , 2006 .

[32]  R. Cherla,et al.  Shiga toxin 1 induces apoptosis through the endoplasmic reticulum stress response in human monocytic cells , 2008, Cellular microbiology.

[33]  T. Kudo,et al.  Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and Aβ-induced cell death , 2004, The Journal of cell biology.

[34]  R. Mirimanoff,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.

[35]  D. Capper,et al.  Stem-cell-like glioma cells are resistant to TRAIL/Apo2L and exhibit down-regulation of caspase-8 by promoter methylation , 2009, Acta Neuropathologica.

[36]  Amy S. Lee,et al.  The glucose-regulated proteins: stress induction and clinical applications. , 2001, Trends in biochemical sciences.

[37]  Eun Hee Kim,et al.  Amiodarone sensitizes human glioma cells but not astrocytes to TRAIL-induced apoptosis via CHOP-mediated DR5 upregulation. , 2011, Neuro-oncology.

[38]  D. Lawrence,et al.  Safety and antitumor activity of recombinant soluble Apo2 ligand. , 1999, The Journal of clinical investigation.

[39]  Junying Yuan,et al.  Cellular response to endoplasmic reticulum stress: a matter of life or death , 2006, Cell Death and Differentiation.

[40]  I. Jeremias,et al.  Cell cycle-arrested tumor cells exhibit increased sensitivity towards TRAIL-induced apoptosis , 2013, Cell Death and Disease.

[41]  Jiangbin Ye,et al.  Modulation of CCAAT/Enhancer Binding Protein Homologous Protein (CHOP)-dependent DR5 Expression by Nelfinavir Sensitizes Glioblastoma Multiforme Cells to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)* , 2011, The Journal of Biological Chemistry.

[42]  M. Lutter,et al.  Biochemical pathways of caspase activation during apoptosis. , 1999, Annual review of cell and developmental biology.

[43]  W. Quax,et al.  The ER stress inducer DMC enhances TRAIL-induced apoptosis in glioblastoma , 2014, SpringerPlus.

[44]  R. Takahashi,et al.  Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[45]  V. Ehemann,et al.  TRAIL-mediated apoptosis in malignant glioma cells is augmented by celecoxib through proteasomal degradation of survivin , 2008, Neuroscience Letters.

[46]  Amy S. Lee,et al.  Stress induction of GRP78/BiP and its role in cancer. , 2006, Current molecular medicine.